Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

Register using your

BUSINESS OF BIOTECHNOLOGY back to topic

Analyst Picks and Pans: Amgen, Coinstar, American Woodmark

Wall Street pored over new trial results for Amgen's anemia drug Aranesp on Aug. 26

BusinessWeek. Added by William Andrews on August 26, 2009

report

save

This article has:

William Andrews shared a reaction in Buying Stocks, U.S. Stock Market, Business of Biotechnology, Stock Research, Stock Investing 90 days ago

“Analyst Picks & Pans: Wall Street researchers offer views on Amgen and Coinstar”

report

Date

Type Channel Author

Search Cancel